Navigation Links
Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
Date:6/18/2010

ROCKVILLE, Md., June 18 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Phacilitate Vaccine Forum Barcelona 2010 conference on June 21 and June 22, 2010 at The Fira Palace, Barcelona, Spain.  Dr. Singhvi is participating in the roundtable discussion, 'Getting ready for the next influenza pandemic: How are recent experiences informing ongoing preparedness strategies?' and will also be speaking on the Case Study:  'Update on novel vaccine technologies and platforms that have been developed for the influenza market.'  

About Novavax

Novavax, Inc. is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology.  The company produces potent VLP-based, recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions.  In 2009, Novavax launched a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India.  Additional information about Novavax is available on the company's website: www.novavax.com.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novavaxs Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
2. NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results
3. NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
4. NOVAVAX to Present at Cowen and Companys 30th Annual Health Care Conference
5. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
6. Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration
7. NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock
8. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
9. Novavax to Present at 8th Annual BIO Investor Forum 2009
10. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
11. NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...   ZappRx, Inc ., a digital health company focused ... announced it closed $25 million in Series B funding led ... in Seattle that is part of ... Series B round included participation from SR One , ... GV (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... , ... A 2-in-1 bottleless water appliance provides both purified ... Texas, here are the ways in which this technology can benefit dental offices: ... fresh, oxygenated water, with both cold and hot options. , Convenience for Dentists ...
(Date:4/23/2017)... , ... April 23, 2017 , ... ... managed services announced the achievement of Cisco Select certification and SMB specialization. ... United States. , In earning the Select Certification, Altura fulfilled the ...
(Date:4/22/2017)... (PRWEB) , ... April 22, ... ... Administration of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its ... Heron-Doerr, PROSHRED® Philadelphia specializes in providing information destruction , recycling, ...
(Date:4/22/2017)... ... 22, 2017 , ... Brian Emmer brings more than 25 ... Business Development at OAKWORKS, Inc. Mr. Emmer is responsible for the leadership ... for the company. Recognized industry-wide as a healthcare innovator, Emmer has executive ...
(Date:4/21/2017)... ... ... An April 10 article in the Daily Mail describes the ... deal about prehistoric ice-age dental practitioners and their primitive and, no doubt, painful techniques. ... dental matter, and that teeth were then filled with bitumen, a substance similar to ...
Breaking Medicine News(10 mins):